President Biden has yet to select a new leader for the Health Resources and Services Administration, the federal agency responsible for the 340B drug pricing program.

NEWS ANALYSIS: Top Job at HRSA Remains Unfilled as Biden Presidency Enters its Sixth Month

Today is President Biden’s 155th day in office, and he has yet to pick someone to run the U.S. Health Resources and Services Administration (HRSA), the federal agency responsible for the 340B drug pricing program.

This normally might be a handicap for HRSA, especially given that it is embroiled in multiple high-stakes lawsuits with drug manufacturers over 340B contract pharmacy. But highly competent temporary leadership at HRSA, plus the close attention 340B is getting from the White House and the U.S. Health and Human Services Department (HHS), makes the vacancy at the top of HRSA’s organizational chart less of a problem, a 17-year veteran of HRSA says.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content